Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy. The widely patented Icare product family is the current cornerstone of the Group’s success.

Revenio Group on kansainvälisillä markkinoilla toimiva suomalainen terveysteknologiakonserni. Tiedot Taloussanomille toimittaa Suomen Asiakastieto Oy. Rating Alfa Myydyin

Yhtiön Revenio Group Oyj liikevaihto oli 744 tuhatta ja tilikauden tulos 13,66 miljoonaa. Revenio Group Oyj is a globally operating health technology, which engages in the detection of glaucoma, osteoporosis, skin cancer, and asthma. It operates through the Revenio Health Tech segment, Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. About Revenio Group Oyj. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others. Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy. The widely patented Icare product family is the current cornerstone of the Group’s success.

Revenio group oy

Revenio-konserniin kuuluvat Revenio Group Oyj, Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Done Medical Oy sekä Oscare Medical Oy. Revenio-konsernin liikevaihto vuonna 2020 oli 61,1 miljoonaa euroa ja liiketulos 17,1 miljoonaa euroa. Puh. 010 665 8110 (ark. klo 8.30 - 16.30) Puh. hinta: 8,4 snt/min, sis alv 24% Revenio Group Oyj Hallitus Lisätietoja: Talousjohtaja Robin Pulkkinen, tel. 050 505 9932 robin.pulkkinen@revenio.fi www.revenio.fi JAKELU: Nasdaq Helsinki Oy Finanssivalvonta Keskeiset tiedotusvälineet www.revenio.fi Revenio-konserni lyhyesti Revenio on kansainvälisillä markkinoilla toimiva terveysteknologiakonserni ja oftalmologisten laitteiden globaali kärkiyhtiö. Revenio-konserniin kuuluvat Revenio Group Oyj, Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Done Medical Oy sekä Oscare Medical Oy. Revenio-konsernin liikevaihto vuonna 2020 oli 61,1 miljoonaa euroa ja liiketulos 17,1 miljoonaa euroa. The Revenio Group consists of Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. The common denominators of Revenio's business operations include patient-oriented screening, follow-up and the global need to make cost savings through preventive health care.

REVENIO GROUP CORPORATION, 59,90, 9,55 M (EUR), +13,02. VERKKOKAUPPA.COM OYJ, 8,48, 4,40 M (EUR), +11,87. HARVIA OYJ NPV, 32,00, 6,56 M

+358 40 580 4774 timo.hilden@revenio.fi www.revenio.fi DISTRIBUTION: Nasdaq Helsinki Oy Financial Supervisory Authority (FIN-FSA) Principal media. www.revenio.fi The Revenio Group in brief Revenio Group Oyj, pörssitiedote, 16.3.2020 klo 16.00.

Revenio Group Oyj on suomalainen pörssiyhtiö. About us. Revenio is a global leader in ophthalmological devices. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters.

Revenio Research puolestaan keskittyy ihosyövän ja astman diagnosointia ja hoidon suunnittelua tukevien järjestelmien kaupallistamiseen. Revenio-konsernin liikevaihto vuonna 2019 oli 49,5 miljoonaa euroa ja liikevoitto 25,5 %. Revenio Group Oyj on listattu Nasdaq Helsinki Oy:ssä. Revenio Group Oyj, Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others. Revenio Group Oyj, Pörssitiedote, 20.3.2019 klo 18.00Revenio Group Oyj:n varsinaisen yhtiökokouksen päätökset 20.3.2019 Revenio Group Oyj Yrityksen Revenio Group Oyj (1700625-7) liikevaihto oli 475118 euroa 2018 ja työllisti 6 henkilöä. Liikevaihto nousi 27,4 %. Tilikauden tulos oli -1,9 miljoonaa euroa ja liikevoittoprosentti oli -402,4 %.

CFO Robin Pulkkinen robin.pulkkinen(at)revenio.fi. Billing addresses E-invoice. Invoice address 003717006257 Operator Liaison Technologies Oy Operator address 003708599126. Paper or PDF. Revenio Group Oyj Serial 16806275 PL 4000 00019 SSC Köp aktier i Revenio Group Oyj - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.
Strängnäs, södermanlands län

Revenio is a global leader in ophthalmological devices. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters.

Trading; Overview; Performance; Key Ratios; Financials; Fact Sheet Fact Sheet; Company Fact Sheet FAQ & Köp aktier i Revenio Group Oyj - enkelt och billigt hos Avanza Bank. HeliAsema: Muu ylin johto(X) OikeushenkilöLiikkeeseenlaskija: Revenio Group Oy. The Revenio Group consists of Revenio Group Corporation, Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Done Revenio Group Oyj, Pörssitiedote, 12.3.2021 klo 9.00.
Ykb kostnad

sälja bostadsrätt mot hyresrätt
lars sundlöf orientering
friktion experiment skola
notch barkarby
söka fondpengar till resa

IAR Systems Group. 4.3 %. Musti Group Oy. 4.3 %. Enea. 3.2 %. Efecte. 3.2 %. Revenio Group Oyj. 2.9 %. Brodrene Hartmann. 2.9 %. 38%.

Klikkaa tästä ja katso reaaliaikainen osakekurssi. 14. lokakuu 2020 Revenio Group Oyj, pörssitiedote, 14.10.2020 klo 21.45. Arvopaperimarkkinalain 9 Revenio Group Oyj on listattu Nasdaq Helsinki Oy:ssä.

Speditør lønn
varberg hotell barn

View Jouni Toijala’s profile on LinkedIn, the world’s largest professional community. Jouni has 1 job listed on their profile. See the complete profile on LinkedIn and discover Jouni’s connections and jobs at similar companies.

Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters. The Revenio Group comprises Revenio Group Oyj, Icare Finland Oy, Icare USA Inc., Revenio Italy S. R. L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V. Jouni started as CEO of Revenio Group Corporation and its' subsidiaries since May 18, 2020. Jouni has experience in international business as well as in the health technology and software businesses. Before joining Revenio, Jouni has worked as CEO at Innokas Medical Oy and Symbio Finland Oy and in executive positions at Nokia UK Ltd and Meridea He also serves on other Boards of Directors, including SNT-Group Oy, and as Chair of the Board of Normiopaste Oy and Member of the Board of Pikespo Invest Oy Ltd and Trimaster Oy. Mr. Tammela has been a member of Revenio’s Board of Directors since April 3, 2007. He is the Chair of the Audit Committee. Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment.

2021-03-17 · The Revenio Group consists of Revenio Group Corporation, Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. In 2020, Revenio Group's net sales totalled EUR 61.1 million, with its net operating profit standing at EUR 17.1 million.

The Revenio Group comprises, Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. The common denominators of Revenio's business operations include patient-led screening, follow-up and the global need to make cost savings in health care via preventive measures.

Revenio-konsernin liikevaihto vuonna 2020 oli 61,1 miljoonaa euroa ja liikevoittomarginaali 28,1 prosenttia. Revenio Group Oyj:n osake on listattu Nasdaq Helsinki Oy… The Revenio Group comprises Revenio Group Oyj, Icare Finland Oy, Icare USA Inc., Revenio Italy S. R. L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V. E-mail addresses: info(at)revenio.fi. Investor contacts.